Antonio Pagán
antoniopagan.bsky.social
Antonio Pagán
@antoniopagan.bsky.social
Assistant Professor at Stanford studying tuberculosis pathogenesis & immunobiology.🇵🇷

https://med.stanford.edu/paganlab.html/
Reposted by Antonio Pagán
In a Stanford Medicine-led clinical trial of a wireless retinal prosthesis, people with advanced macular degeneration regained enough vision to read books and subway signs.
stan.md/4qkYHMu
Eye prosthesis is the first to restore sight lost to macular degeneration
In a Stanford Medicine-led clinical trial of a wireless retinal prosthesis, people with advanced macular degeneration regained enough vision to read books and subway signs.
stan.md
October 20, 2025 at 5:29 PM
Reposted by Antonio Pagán
🚨Publication alert: Where does immunotherapy happen? What can the fish teach us about human pathology? And a dendritic cell is having a friend for dinner. Cancer immunology goes live, now in @cp-cell.bsky.social.
Here is a concise summary of a pretty big study 🧵. Let’s go (appetizer👇)
October 18, 2025 at 5:46 PM
Reposted by Antonio Pagán
Learn more and register for the upcoming Stanford.Berkeley.UCSF Next Generation Faculty Symposium on 9/10/25: czbiohub.zoom.us/webinar/regi...
September 5, 2025 at 6:56 PM
Reposted by Antonio Pagán
Bedaquiline resistance driven by the MmpS5L5 efflux pump is threatening the drug regimens used to treat MDR-TB.

In our new preprint, we used structural and genetic approaches to better understand how MmpS5L5 effluxes bedaquiline and how future resistance may evolve. 🧵🔽

#TBsky #MicroSky #TB
Structural and functional analysis of the Mycobacterium tuberculosis MmpS5L5 efflux pump presages a pathway to increased bedaquiline resistance
Bedaquiline, an antitubercular drug that targets ATP-synthase, is a key component of a new oral drug regimen that has revolutionized the treatment of multi drug resistant tuberculosis. Clinical bedaqu...
www.biorxiv.org
June 26, 2025 at 10:30 AM
Reposted by Antonio Pagán
Heart disease is the world’s leading killer, and tackling it demands decoding the multi-gene networks driving disease progression 🫀

Learn how researchers used Medaka fish plus high-throughput heartbeat imaging to build a biomarker toolkit for early screening.

www.nature.com/articles/s41...
May 13, 2025 at 9:40 AM
Reposted by Antonio Pagán
@katherinejwu.com getting straight to the ❤️ of the crisis. This current attack on science must be stopped to protect all Americans.
February 15, 2025 at 10:15 PM
Reposted by Antonio Pagán
This is outstanding. All academic scientists should be required to watch this.
Make sure you, your trainees, and anyone else who might listen to you understands what "indirects" actually are, how they are established, and what Universities contribute. H/T @rodallab.bsky.social

Please share widely!

www.youtube.com/watch?v=yxTD...
Facilities and Administrative (F&A) Costs Explainer
YouTube video by Association of American Universities
www.youtube.com
February 11, 2025 at 7:52 PM
Reposted by Antonio Pagán
A Direct Hit, by @holdenthorp.bsky.social @science.org
www.science.org/doi/full/10....
"This is a moment to unite."
February 11, 2025 at 3:18 PM
Reposted by Antonio Pagán
Pro-inflammatory macrophage activation does not require inhibition of oxidative phosphorylation | EMBO reports

www.embopress.org/doi/full/10....
Pro-inflammatory macrophage activation does not require inhibition of oxidative phosphorylation | EMBO reports
imageimageA reduction in oxidation phosphorylation is considered to be a hallmark of pro-inflammatory macrophage polarization. This study shows that respiratory inhibition is not required for macropha...
www.embopress.org
January 6, 2025 at 3:58 PM
Reposted by Antonio Pagán
Please retweet! Open rank faculty search in the basic sciences at UCLA David School of Medicine. Multiple positions are available - the application deadline is 19th January. Please apply here:

recruit.apo.ucla.edu/JPF10062
Open Rank Faculty Position in David Geffen School of Medicine at UCLA
University of California, Los Angeles is hiring. Apply now!
recruit.apo.ucla.edu
December 20, 2024 at 2:11 AM